Overcoming the Limitation of GWAS Platforms Using Systems Biology Approach
Background: Type 2 diabetes (T2D) is one of the major multi-factorial disorders resulting in various health problems. Despite enormous data generated through GWAS, complete T2D heritability is yet to be achieved. Most of the GWAS platforms are also underrepresented in regulatory genes
and nonsynonymous SNPs (nsSNPs) and these may therefore remain undetected.
Objective: The present study is an attempt to delineate additional key players of T2D employing systems biology approach on available GWAS results.
Method: Genes belonging to significant biological processes (BP) were identified as key genes. Key genes were then used for building gene set enrichment of T2D associated genes using gene-gene and protein-protein networks. The key genes and their connected genes were further used to explore networks involving miRNAs and Transcription Factors (TF), for this, computational feed-forward loops (FFLs) were used. Thereafter, connected genes were also looked for non-synonymous SNPs (nsSNPs) and their effect on structure-function of proteins as elucidated by in-silico analysis.
Results: Carbohydrate and Glucose homeostasis (p=1.33E-05) were the significant BP identified which involves HNF1A, PCK1, IRS1, WFS1, PARG and TCF7L2 genes. Computational feed-forward loops showed involvement of regulatory genes such as hsa-miR17, hsa-miR141 (miRNAs) and CTCF (TF) in T2D. Two nsSNPs in the associated genes, PCK1 (I267V) and PEPD (R388H) were found as deleterious and damaging to protein structure.
Conclusion: The present study provides new approach towards underpinning plausible genetic heritability to T2D. Experimental validation of these regulatory genes and nsSNPs may provide added insights into pathophysiology of T2D, and holds promise for personalized medication toT2D.
Objective: The present study is an attempt to delineate additional key players of T2D employing systems biology approach on available GWAS results.
Method: Genes belonging to significant biological processes (BP) were identified as key genes. Key genes were then used for building gene set enrichment of T2D associated genes using gene-gene and protein-protein networks. The key genes and their connected genes were further used to explore networks involving miRNAs and Transcription Factors (TF), for this, computational feed-forward loops (FFLs) were used. Thereafter, connected genes were also looked for non-synonymous SNPs (nsSNPs) and their effect on structure-function of proteins as elucidated by in-silico analysis.
Results: Carbohydrate and Glucose homeostasis (p=1.33E-05) were the significant BP identified which involves HNF1A, PCK1, IRS1, WFS1, PARG and TCF7L2 genes. Computational feed-forward loops showed involvement of regulatory genes such as hsa-miR17, hsa-miR141 (miRNAs) and CTCF (TF) in T2D. Two nsSNPs in the associated genes, PCK1 (I267V) and PEPD (R388H) were found as deleterious and damaging to protein structure.
Conclusion: The present study provides new approach towards underpinning plausible genetic heritability to T2D. Experimental validation of these regulatory genes and nsSNPs may provide added insights into pathophysiology of T2D, and holds promise for personalized medication toT2D.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics
Keywords: Diabetes mellitus type 2; MicroRNAs; genome wide association studies; single nucleotide polymorphism; systems biology; transcription factor
Document Type: Research Article
Publication date: 2017-04-01
- Current Bioinformatics aims to publish all the latest and outstanding developments in bioinformatics. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a wide range of the integration of biology with computer and information science.
The journal focuses on reviews on advances in computational molecular/structural biology, encompassing areas such as computing in biomedicine and genomics, computational proteomics and systems biology, and metabolic pathway engineering. Developments in these fields have direct implications on key issues related to health care, medicine, genetic disorders, development of agricultural products, renewable energy, environmental protection, etc.
Current Bioinformatics is an essential journal for all academic and industrial researchers who want expert knowledge on all major advances in bioinformatics.